Come up with a name for your new list and we'll add to it:
OPX Biotechnologies raised a round of funding on April 19, 2010. Investors include
Advanced Research Technologies.
The OPX EDGE (Efficiency Directed Genome Engineering) technology platform enables rapid, rational, and robust optimization of microbes and bioprocesses to manufacture bioproducts with equivalent perfo…